The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Successful treatment of a child with t(15;19)-positive tumor.

På svenska

Author

Summary, in English

A subset of poorly differentiated carcinomas is characterized by the translocation t(15;19)(q13;p13), resulting in a BRD4/NUT fusion gene. Typically, this tumor affects children or young adults, with a predilection for midline head and neck or thoracic structures. The clinical course is invariably fatal, in spite of intensive chemotherapy and radiotherapy. We here present the successful treatment of a 10-year-old boy who presented with a BRD4/NUT-positive undifferentiated tumor in the iliac bone. The patient was selected for combined modality therapy, and has remained in complete continuous remission for close to 13 years. The findings show that t(15;19)-BRD4/NUT-positive tumors may arise in locations more typical for other pediatric tumors, such as Ewing sarcoma, and that they not always display epithelial differentiation. More importantly, our results also demonstrate that at least some patients with t(15;19)-positive tumors may be successfully treated.

Publishing year

2007

Language

English

Pages

1015-1017

Publication/Series

Pediatric Blood & Cancer

Volume

49

Document type

Journal article

Publisher

John Wiley & Sons Inc.

Topic

  • Pediatrics

Keywords

  • chemotherapy
  • Ewing tumor
  • NUT
  • t(15
  • 19)
  • BRD4

Status

Published

ISBN/ISSN/Other

  • ISSN: 1545-5017